Drug Delivery Partnerships 2012(藥物傳遞•合作夥伴關係會議)
2012年1月25-27日 - 內華達州拉斯維加斯

時間和金錢一樣貴重。必須有效使用金錢。您若想有最可靠的業績,考慮將時間和錢花在有益的藥物傳遞會議上,請勿錯過Drug Delivery Partnerships(DDP)。再也找不到有提供想見的人和想聽的內容之會議了。DDP有過去15年業績,將成為與今後商務更加相連的內容。

DDP是全球最大的藥物傳遞會議,為提高長期收益,以加速藥劑上市及延長其生命週期為目的,是能找到新合夥人、藥物傳遞技術和新處方設計開發策略的機會。

SUBMIT YOUR PROPOSAL NOW!
The Institute for International Research is looking for papers for its upcoming 16th Annual Drug Delivery Partnerships Conference, to be held on January 25-27th, 2012 in Las Vegas, NV at the Caesar's Palace hotel. This meeting sets the stage for accelerated pharmaceutical innovation in the drug delivery space by being the meeting place to find strategic partnerships to get drugs to market cheaper and faster and ensure prolonged lifecycles.

Choose your language
Japanese
Korean

創新獎(innovation award)
Drug Delivery Partnerships Products of the Year awards Ceremony(藥物傳遞合作產品年度授賞典禮)中,授予今年有最創新活動的科學家這個獎。
是醫藥品業界最大且最長的活動,作為深受好評的藥物傳遞會議,今年亦舉行最好且有益的活動。
2012年的DDP Awards category
award image
技術創新
出色的合作
業界的偉業
關注的"企業
產業會議彙總曆
Submission Guidelines & Details
In your abstract, please provide the following:

Proposed Title of Session: Objective and purpose
  • A descriptive paragraph of 3-4 sentences describing what is unique or special about the information you plan to share- aka Background Information
  • 3-4 bullet points highlighting the game changing strategies, tools and techniques attendees will walk away with- aka Key Takeaways
We are currently recruiting drug delivery and formulation executives who can share NEW DATA through detailed case studies related to leveraging the value of drug formulation and delivery to improve product pipelines, patient outcomes and boost innovation. Some of the categories of topics are:
  • Drug delivery partnerships as a strategy for pipeline value creation
  • Lessons learned to overcome biologic stability and manufacturing issues
  • Re-formulation for life cycle management
  • Innovation for OTC drugs
  • Marketplace opportunities for biosimilars
  • Regional preference for drug delivery methodologies in emerging markets
  • Current landscape for nanoparticles as drug carriers
  • Current reimbursement roadmap
***This list is merely suggestive, not comprehensive nor obligatory.
Do you want to reach this audience?
We have a limited number of slots available for solution providers/consultants.

© 2009-2010 IIR Holdings, LTD. All Rights Reserved.
營運 : Institute for International Research (IIR)代理商 日商環球訊息有限公司